Metastatic Colorectal Cancers Recruiting Phase 1 Trials for Regorafenib (DB08896)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03712943Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal CancerTreatment
NCT03081494Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal CancerTreatment